N4 Pharma (STU:0GO) Total Stockholders Equity : €1.31 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is N4 Pharma Total Stockholders Equity?

N4 Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €1.31 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. N4 Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was €0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. N4 Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

N4 Pharma Total Stockholders Equity Historical Data

The historical data trend for N4 Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

N4 Pharma Total Stockholders Equity Chart

N4 Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1.16

4.04

2.51

2.40

1.31

N4 Pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															2.51	1.62	2.40	1.68	1.31

N4 Pharma (STU:0GO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

N4 Pharma's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1.309	-	0)	/	268.78
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

N4 Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1.309
	=	0.00

N4 Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of N4 Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

N4 Pharma (STU:0GO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » N4 Pharma PLC (STU:0GO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N4P.GB:UK N4P:UK

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.n4pharma.com

N4 Pharma PLC is the holding company for N4 UK. N4 UK is a specialist pharmaceutical company engaged in the development of nanoparticle silica delivery systems to improve the cellular delivery and potency of cancer treatments and vaccines. The company operated in one business segment, that of the development and commercialisation of medicines via its delivery system called Nuvec.

N4 Pharma (STU:0GO) Headlines

No Headlines